Skip to main content

Table 3 Adjusted Cox estimates of 5- and 10-year relapse-free survival by BCI categories

From: Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study

BCI risk

Number of patients (%)

5-year RFSa

10-year RFSa

Low

145 (50)

94 %

87.5 %

Intermediate

69 (24)

91.8 %

83.9 %

High

78 (27)

81.5 %

74.7 %

  1. BCI Breast Cancer Index, RFS risk-free survival
  2. aAdjusted Cox estimates of RFS with adjustment for treatment, MA.14 stratification factors, and pathologic tumor stage